Stronger Sell Today ABUS ranks #6194 as SELL CANDIDATE #6194 Weaker Sell

ABUS stock forecast Arbutus Biopharma Corporation

ABUS stock forecast





Social Sentiment for ABUS

Today's data is from 1 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment 0.00

Will ABUS stock price go up or down on Tue, 28 May 2019?


Arbutus Biopharma Corporation Forecast and Stock Analysis

Technical ABUS stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-04-17 Loss -40.65%
Shorts n/a
Insider % n/a
Institutional % 49.40%
Beta 2.32
ROA -32.23%
Price to book USD 2.32
P/E Ratio -1.48
Next Earnings Date 2019-08-14

Arbutus Biopharma Corporation fell by -4.31% in the last day ( Thursday, 23rd May 2019 ) from $2.09 to $2.00 and has now fallen 6 days in a row. During day the stock fluctuated 7.79% from a day low at $1.99 to a day high of $2.15. The price has fallen in 7 of the last 10 days and is down by -15.61% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -53 993 shares and in total 277 232 shares bought and sold for approximately $554 464.00.

Quick summary:

  • 30 day high of the ABUS stock price was $3.16 and low was $1.99.
  • 90 day high was $4.75 and low was $1.99.
  • 52 week high for the Arbutus Biopharma Corporation - $12.60 and low - $1.99.


Arbutus Biopharma Corporation lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $1.77 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -41.31% during the next 3 months and, with 90% probability hold a price between $1.04 and $1.88 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Arbutus Biopharma Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.29 and $2.93. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday May 16, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 24 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $2.00 Resistance: $2.09


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 7.79%. For the last week the stock has had a daily average volatility of 7.16%.

Arbutus Biopharma Corporation is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

7.16 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Stronger Sell Today ABUS ranks #6194 as SELL CANDIDATE #6194 Weaker Sell
ABUS $2.00 ($-0.09 -4.31%)
ABUS is down $0.09 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for ABUS based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for readers.

Click here – the ABUS analysis is free »

Will ABUS stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank